Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Perhaps but if the market perception is the payout will be lessened, even if in reality it probably won't, biotech is going to pull back. Perhaps only temporary and a buying opp but pullback nonetheless.
Thx
Not sure I follow. If the cost to produce a drug remains the same (or goes higher actually) but the potential payout is limited or lowered by restrictions on pricing, how are they not related?
and he wants to put limits on pricing.
But curiously biotech rages on.
That's some understanding of realistic and objective you have there.
Nobody in their right mind would write something like that. It would be career suicide.
Give it up already
Only problem is that is what you've been saying that for several years and the stock is still trading at the IPO price 20 + years later.
Good luck with that thought process because you guys are going to need it.
What difference does it make? It was stopped at 33% for futility! That's awful not interesting!
There was nothing Courageous about it.
"The decision to stop the trial was based on the recommendation of the study's Independent Data Monitoring Committee (IDMC) following a pre-specified interim analysis performed after 33% of targeted overall events (patient deaths) in the study were reached. Results of the analysis demonstrated that the bavituximab plus docetaxel group did not show a sufficient improvement in overall survival as compared to the docetaxel group to warrant continuation of the study."
Just wondering what it's going to take for the PPHM bulls to throw in the towel?
It's really sad to see so many people still holding on.
RE:Labu/Labd
These are 3X leveraged that are not meant for "investing" because as you hold long term, decay and volatility will eat you alive.
I have been day trading and swing trading them recently and as someone else mentioned, they are not for the faint of heart. They take extreme discipline with stops and profit taking. I think LABD would make a good hedge in the event that the biotech market gets ahead of itself again (and it will someday).
FYI, Ameritrade would not let me short LABU today. Had to go long LABD.
EDIT: Days/few weeks at most for a hold, but I usually sell out at the end of the day. I read somewhere that you avoid the fees if you don't hold them. Not sure.
I thought you called the bottom last week?
Yes one up day for the S & P and a barely up day for Biotech and all the world's problems are solved.
Sure
Two facts that mean absolutely nothing
The last day for tax loss selling is today not the 24th as you posted
How long can they keep KBIO halted?
Again Sarissa owns US Merck this is a totally different company with no attachment.
"Pride goeth before the fall"
You have the wrong Merck and the other Merck didn't fair so well the last time they dealt with Ariad.
SMH
This I find fascinating:
What's to guess? Evan Greebal, who was indicted with him today. Marty boasted how everything was done with outside counsel's blessing, so the FBI indicted him as well. The indictment speaks of co-conspirator 1 (who I assume is Marty's partner), corrupt employee 1 and corrupt employee 2. I would imagine they will have a few sleepless nights wondering if the FBI will come a knockin on their doors.
The indictment is a great read if you have 30 mins.
http://media.bloomberg.com/bb/avfile/rjMmmf1jHzI0
Sure $6 companies always get bought out for $28. Especially when one offered $10 and nobody else made an offer.
The logic around here is comical
You realize they have a cash burn problem don't you? How do they "let the pipeline mature" and solve that?
Anyone hear anything on the FMI investor conference to warrant the 5% sell off yesterday?
Or just normal trading nonsense
You are not alone my man. Just think of the institutional investors that Berger snookered into buying the offering at $19.50?
Isn't that exactly what the four resigning employees accused Berger of in their resignation letter?
Chickens came home to roost
As an FMI investor currently underwater, I'd love to see Roche come in and buy the remaining 35%, but I don't think there is much of a chance of that happening anytime soon
What makes you think FMI would sell to them at a discount price?
The markets sure have a strange way of showing their love huh
Thanks for the response Peter. Any suggestions to raise hdl levels? I've started taking omega complex again but that allegedly comes with prostate issues.
I can't come up with a logical reason as to why the low HDL's.
Any idea?
A little OT, but I recently took a physical and my blood work was pretty good except my HDL levels were abnormally low at 21. My total cholesterol was a little higher than Id like at 174.
I started taking Slo Niacin from Costco which is 500 mg once a day.
Aside from that weird hot flush, does anyone know of any other side effects they would care to share?
Also, I'd swear that it helps burn fat because I haven't changed much and I've dropped a few pounds that have been tough to lose.
TIA
Perhaps you have heard of a little NVS mtor inhibitor named Afinitor (Everolimus)?
Why buy the cow when the milk is cheap?
Find it hard to believe Roche misread the market this severely only 4 months ago
Anyone have any idea WTF is going on with FMI?
Too bad Roche didn't just buy the whole thing...
There's a 3 year standstill but how long till they come back for the rest?
Let me refresh your memory. Back in 2013, Adam Feuerstein wrote his now infamous article claiming a short seller friend of his told him there were toxicity issues with Ponatinib. Most Ariad investors called him a "shill for the shorts".
Harvey Berger, on the other hand, swore on a stack of bibles that there were no such toxicity issues. He vowed that the only thing that they were seeing that Ponatinib was "well tolerated" (even though we now know that all the while the FDA was in constant contact with Ariad about Ponatinib's problems). He even held his now infamous "if I could buy more I would" press conference to refute Adam's Flavus column.
Remarkably, even though Adam Feuerstein turned out to be 100% correct and Harvey Berger was completely lying through his teeth, some here still call Feuestein a shill while they pray that Berger keeps control of Ariad.
That's truly unbelievable.
So let's see if I have this straight...Berger would threaten to sell Ariad cheap to spite Denner even though he would stand to lose tens of millions.
Sounds like negotiation mastery of you ask me
Good grief
Vintagecharm alias born 4/9/1015 huh...the ARIAD spin machine is working overtime on message boards to save Berger.
Sad really but good riddance Harv
If Denner loses and bails, this turd is going back to sub $5.
Then you can sit and hold for 20 more years while your hero Berger sucks every nickel he can out of the company and the shareholders get another 0% gain to show for it.
Oh wait Harv's got a plan and the stocks going to $50. Sure it is.
What's the old saying...There's a what born every minute?